Subscribe
Subscribe
乐普医疗
Engaged in the R&D, production and sales of cardiovascular disease plant intervention diagnosis and treatment equipment and cardiovascular drugs.
Lepu Medical, founded in June, 1999 and headquartered in Beijing, is an enterprise engaged in the R&D, production and sales of cardiovascular drugs and cardiovascular disease plant interventional diagnosis and treatment equipment . The founder is Pu Zhongjie. Listed on the SZSE on October 30, 2009, the company's major shareholders are Luoyang Ship Material Research Institute, Pu Zhongjie and WP Medical Technologies, INC. Rivals that have direct and indirect competition with Lepu Medical include Peijia, Kintor, Aprea Therapeutics, Viela, etc.
Engaged in the R&D, production and sales of cardiovascular disease plant intervention diagnosis and treatment equipment and cardiovascular drugs.
Lepu Medical, founded in June, 1999 and headquartered in Beijing, is an enterprise engaged in the R&D, production and sales of cardiovascular drugs and cardiovascular disease plant interventional diagnosis and treatment equipment . The founder is Pu Zhongjie. Listed on the SZSE on October 30, 2009, the company's major shareholders are Luoyang Ship Material Research Institute, Pu Zhongjie and WP Medical Technologies, INC. Rivals that have direct and indirect competition with Lepu Medical include Peijia, Kintor, Aprea Therapeutics, Viela, etc.
TC Medical's 1H 2020 Revenue Totals CNY 738 Mn, Down 12.87% YoY
France-China Cooperation Fund Closes First Deal in Dutch Ophthalmic Expert
Liquid Biopsy Developer Huidu Medical Closes Series B-1 for Precise Biomarker
Chinese Genetic-tech Gomics Closes Pre-Series A to Commerce
Continuous Glucose Monitor Maker Infinovo Closes Series B
Public Funds' Allocation to the Pharmaceutical Industry Reaches Record High
Health Monitor App Xiyou Closes Series A to Build New Pharma Retail Ecosystem
Mingdu Tech Closes Series A+ of CNY 80 Mn for Digitalization in Life Science
Wider Health Insurance Coverage Benefits Online Healthcare Business
JW Therapeutics Buys Hong Kong Anti-cancer Drug Maker Syracuse Biopharma
Medtronic Invests in Beijing Surgical Robots Maker Sinovation
Ali Health Denies Alibaba Selling Shares Rumor
Alibaba Sells 154 Million Ali Health Shares
Per Capita Healthcare Spending in China Decreases by 9.9% in H1 2020
HKEX-listed Venus MedTech Engages inMedical Investment
HKEX-listed Chinese Double Medical Gets CE Marked
Junshi Biosciences Lands on Star Market, Raising CNY 4.497 Bn
Heart Voice Closes Pre-Series A to Inject AI into Electrocardiograph
Salubris Pharma Forecasts Over 65% Drop in Net Profit
Hillhouse Will Inject USD 1 billion in BeiGene's Share Sale
EqualOcean is an international information service provider and investment research firm that aims to become a global platform for industrial innovation.
We strive to make technology inclusive, accessible and transparent.
Join over 70,000 of your peers
Beijing
9 Xiaguangli, 10F Block A CEC Development Mansion, Chaoyang Dc, Beijing 100125, China
Shanghai
A002, 5F, Ai Tower, 701 Yunjin Road, Xuhui Dc, Shanghai 200232, China
New York
800 Third Ave, 28F, New York, NY 10022, USA
Cooperation strategy
Products & prices
Customers & evaluation
